Also, a nearly 2-fold increase in the risk of CVEs associated with olanzapine was calculated but this estimate did not reach statistical significance [ 41 ].
← all excerpts
Antipsychotics for the treatment of behavioral and psychological symptoms of dementia (BPSD).
1
—
—